697.08
price up icon0.34%   2.38
pre-market  プレマーケット:  697.08  
loading
前日終値:
$694.70
開ける:
$688.72
24時間の取引高:
1.01M
Relative Volume:
1.12
時価総額:
$86.97B
収益:
$344.58B
当期純損益:
$2.83B
株価収益率:
31.92
EPS:
21.84
ネットキャッシュフロー:
$1.63B
1週間 パフォーマンス:
+2.61%
1か月 パフォーマンス:
+6.38%
6か月 パフォーマンス:
+37.03%
1年 パフォーマンス:
+32.54%
1日の値動き範囲:
Value
$686.64
$702.00
1週間の範囲:
Value
$673.46
$702.21
52週間の値動き範囲:
Value
$464.42
$728.32

Mckesson Corporation Stock (MCK) Company Profile

Name
名前
Mckesson Corporation
Name
セクター
Healthcare (1151)
Name
電話
972-446-4800
Name
住所
6555 STATE HIGHWAY 161, IRVING, TX
Name
職員
51,000
Name
Twitter
@McKesson
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
MCK's Discussions on Twitter

MCK を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Distribution icon
MCK
Mckesson Corporation
697.08 86.97B 344.58B 2.83B 1.63B 21.84
Medical Distribution icon
COR
Cencora Inc
286.74 55.07B 303.19B 1.40B -638.10M 7.03
Medical Distribution icon
CAH
Cardinal Health Inc
134.71 32.56B 222.16B 1.31B -486.00M 5.36
Medical Distribution icon
HSIC
Henry Schein Inc
64.73 8.04B 12.50B 314.00M 421.00M 2.44
Medical Distribution icon
OMI
Owens Minor Inc
6.93 534.60M 10.42B -38.77M 323.54M -0.51

Mckesson Corporation Stock (MCK) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-04 再開されました Mizuho Neutral
2024-11-07 アップグレード Robert W. Baird Neutral → Outperform
2024-09-24 ダウングレード Robert W. Baird Outperform → Neutral
2024-09-05 繰り返されました Leerink Partners Outperform
2024-08-08 繰り返されました Mizuho Neutral
2024-02-26 開始されました Leerink Partners Outperform
2024-01-03 開始されました Barclays Overweight
2023-12-14 開始されました Wells Fargo Equal Weight
2023-03-31 開始されました Citigroup Buy
2022-08-22 再開されました Morgan Stanley Overweight
2022-07-06 ダウングレード Argus Buy → Hold
2022-06-07 アップグレード Deutsche Bank Hold → Buy
2022-04-01 再開されました Credit Suisse Outperform
2022-02-04 ダウングレード Deutsche Bank Buy → Hold
2022-01-07 アップグレード Credit Suisse Neutral → Outperform
2021-11-02 繰り返されました Barclays Overweight
2021-11-02 繰り返されました BofA Securities Buy
2021-11-02 繰り返されました Evercore ISI Outperform
2021-11-02 繰り返されました Jefferies Buy
2021-03-30 アップグレード Argus Hold → Buy
2020-11-02 アップグレード Barclays Equal Weight → Overweight
2020-08-04 アップグレード Deutsche Bank Hold → Buy
2020-05-22 アップグレード Wolfe Research Peer Perform → Outperform
2020-05-15 アップグレード UBS Neutral → Buy
2020-04-23 再開されました Credit Suisse Neutral
2020-03-18 アップグレード Goldman Neutral → Buy
2020-03-13 アップグレード Guggenheim Neutral → Buy
2020-02-07 アップグレード Robert W. Baird Neutral → Outperform
2020-01-10 アップグレード Morgan Stanley Equal-Weight → Overweight
2019-09-12 開始されました Deutsche Bank Hold
2019-08-05 ダウングレード Wolfe Research Outperform → Peer Perform
2019-07-22 開始されました Guggenheim Neutral
2019-01-17 開始されました UBS Neutral
2018-10-26 繰り返されました Barclays Equal Weight
2018-07-20 ダウングレード Robert W. Baird Outperform → Neutral
2018-05-29 繰り返されました Leerink Partners Mkt Perform
2018-03-08 開始されました Barclays Equal Weight
2018-02-27 再開されました BofA/Merrill Buy
2018-02-02 繰り返されました Mizuho Neutral
2018-01-24 アップグレード Jefferies Hold → Buy
すべてを表示

Mckesson Corporation (MCK) 最新ニュース

pulisher
Apr 18, 2025

Jim Cramer Labels McKesson Corporation (MCK) a “Money Machine – A Must-Own Middleman” - Insider Monkey

Apr 18, 2025
pulisher
Apr 18, 2025

McKesson Careers | The future of health starts with you. - McKesson Careers

Apr 18, 2025
pulisher
Apr 18, 2025

McKesson Launches Precision Care Companion for Biomarker-Driven Cancer Care - HIT Consultant

Apr 18, 2025
pulisher
Apr 17, 2025

McKesson is medicine for Elite Investors in market chaos - Citywire

Apr 17, 2025
pulisher
Apr 17, 2025

Jim Cramer’s List of 16 Stocks to Buy Right Now - Insider Monkey

Apr 17, 2025
pulisher
Apr 17, 2025

Citigroup Adjusts Price Target on McKesson to $800 From $685, Maintains Buy Rating - marketscreener.com

Apr 17, 2025
pulisher
Apr 17, 2025

McKesson provides Elite Investors with medicine for market choas - Citywire

Apr 17, 2025
pulisher
Apr 16, 2025

McKesson (MCK) Ascends While Market Falls: Some Facts to Note - Yahoo Finance

Apr 16, 2025
pulisher
Apr 16, 2025

McKesson Launches Collaboration to Boost Precision Oncology Adoption - Inside Precision Medicine

Apr 16, 2025
pulisher
Apr 16, 2025

McKesson (NYSE:MCK) Launches Precision Care Initiative Transforming Oncology Treatment - Yahoo Finance

Apr 16, 2025
pulisher
Apr 16, 2025

Jim Cramer: McKesson (MCK) Is a “Money Machine” – Funds Keep Flowing In - Yahoo Finance

Apr 16, 2025
pulisher
Apr 16, 2025

McKesson Unveils Precision Care Companion, Revolutionizing Precision Medicine in Community Oncology - Business Wire

Apr 16, 2025
pulisher
Apr 15, 2025

McKesson Corporation (MCK): Among the Best Value Dividend Stocks to Buy According to Billionaires - Yahoo Finance

Apr 15, 2025
pulisher
Apr 14, 2025

3 Dividend Stocks Built for Stability as Growth Trades Cool Off - Investing.com

Apr 14, 2025
pulisher
Apr 13, 2025

Middlemen Always Work.” – Jim Cramer’s Love for McKesson Corporation (MCK) - Insider Monkey

Apr 13, 2025
pulisher
Apr 11, 2025

GS1 US to host webinar on McKesson, Target supply chain traceability - Supermarket Perimeter

Apr 11, 2025
pulisher
Apr 11, 2025

GS1 to host webinar on McKesson, Target supply chain traceability - Supermarket Perimeter

Apr 11, 2025
pulisher
Apr 11, 2025

McKesson (MCK) Sees Price Target Boost to $755 by BofA | CAH Sto - GuruFocus

Apr 11, 2025
pulisher
Apr 11, 2025

McKesson To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga

Apr 11, 2025
pulisher
Apr 11, 2025

McKesson and Wegmans: A Long-Standing Partnership in Advancing Pharmacy - NEWS CHANNEL NEBRASKA

Apr 11, 2025
pulisher
Apr 10, 2025

Why the Market Dipped But McKesson (MCK) Gained Today - Yahoo Finance

Apr 10, 2025
pulisher
Apr 10, 2025

Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know - Yahoo Finance

Apr 10, 2025
pulisher
Apr 09, 2025

Jonathan Jackson from Illinois’s 1st district makes notable trades in Microsoft, Salesforce, and McKesson - Investing.com India

Apr 09, 2025
pulisher
Apr 09, 2025

This Medical Supplies Distributor Dodges A Tariff Bullet - Investor's Business Daily

Apr 09, 2025
pulisher
Apr 09, 2025

Evercore ISI Adjusts Price Target on McKesson to $740 From $675, Maintains Outperform Rating - MarketScreener

Apr 09, 2025
pulisher
Apr 08, 2025

McKesson (MCK) Stock Moves -1.38%: What You Should Know - Yahoo Finance

Apr 08, 2025
pulisher
Apr 08, 2025

McKesson opens registration for 2025 ideaShare conference - Drug Store News

Apr 08, 2025
pulisher
Apr 08, 2025

Registration Opens for Annual McKesson ideaShare Conference - Yahoo Finance

Apr 08, 2025
pulisher
Apr 08, 2025

Quad-C Management Completes the Sale of PRISM Vision to McKesson - PR Newswire

Apr 08, 2025
pulisher
Apr 08, 2025

Quad-C sells stake in Prism Vision to McKesson Corporation - pehub.com

Apr 08, 2025
pulisher
Apr 05, 2025

McKesson Corporation (MCK): Jim Cramer’s Top Pick – Why He Thinks McKesson Can ‘Jack Prices Up’ - Insider Monkey

Apr 05, 2025
pulisher
Apr 05, 2025

Zacks Research Brokers Lift Earnings Estimates for McKesson - Defense World

Apr 05, 2025
pulisher
Apr 04, 2025

Rite Aid weighs repeat bankruptcy filing, WSJ reports - MarketScreener

Apr 04, 2025
pulisher
Apr 04, 2025

McKesson In Huge Group New To IBD 50: Check Out Which Stocks Just Came On – And Off – IBD's Top Stock Screens - Investor's Business Daily

Apr 04, 2025
pulisher
Apr 04, 2025

McKesson stock soars to all-time high of $726.13 By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 04, 2025

McKesson stock soars to all-time high of $726.13 - Investing.com

Apr 04, 2025
pulisher
Apr 03, 2025

Mizuho raises McKesson stock target to $690, maintains neutral By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

MCK Stock Gains as PRISM Acquisition Adds High-Growth Business - TradingView

Apr 03, 2025
pulisher
Apr 03, 2025

McKesson Corporation completed the acquisition of 80% stake in PRISM Vision Group from Quad-C Management, Inc. - MarketScreener

Apr 03, 2025
pulisher
Apr 03, 2025

Deutsche Bank Adjusts Price Target on McKesson to $692 From $700, Maintains Buy Rating - MarketScreener

Apr 03, 2025
pulisher
Apr 03, 2025

Mizuho Adjusts Price Target on McKesson to $690 From $630, Maintains Neutral Rating - MarketScreener

Apr 03, 2025
pulisher
Apr 03, 2025

McKesson price target raised to $690 from $630 at Mizuho - TipRanks

Apr 03, 2025
pulisher
Apr 03, 2025

Mizuho raises McKesson stock target to $690, maintains neutral - Investing.com India

Apr 03, 2025
pulisher
Apr 03, 2025

McKesson Shares Up Over 2% After Key Signal - Benzinga

Apr 03, 2025
pulisher
Apr 03, 2025

McKesson Gets Drugs to Patients. Buy the Stock for Healthy Returns. - Barron's

Apr 03, 2025
pulisher
Apr 02, 2025

McKesson (MCK) Poised for Growth in Pharmaceutical Distribution - GuruFocus

Apr 02, 2025
pulisher
Apr 02, 2025

Whistleblower Asks Justices to Revive Suit Against McKesson Unit - Bloomberg Law News

Apr 02, 2025
pulisher
Apr 02, 2025

McKesson: Morgan Stanley's Top Choice For Pharmaceutical Gains - Finimize

Apr 02, 2025
pulisher
Apr 02, 2025

McKesson Likely to See Strong Growth Amid Favorable Pharma Sector, Morgan Stanley Says - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

McKesson completes $850M majority stake purchase in eye care company - The Business Journals

Apr 02, 2025

Mckesson Corporation (MCK) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
medical_distribution COR
$286.74
price up icon 0.81%
medical_distribution CAH
$134.71
price up icon 0.26%
$64.73
price up icon 2.28%
medical_distribution OMI
$6.93
price up icon 2.36%
medical_distribution AHG
$1.14
price up icon 14.00%
大文字化:     |  ボリューム (24 時間):